VIVUS, Inc. (NASDAQ:VVUS) – Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) Stendra Gets FDA Go-Ahead For 15 Minutes Prior Use

Boston, MA 09/19/2014 (wallstreetpr) – Stendra, the erectile dysfunction drug developed collaboratively by VIVUS, Inc. (NASDAQ:VVUS) and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) has been given the nod by the U.S. Food and Drug Administration to be used 15 minutes earlier. It is crucial to point out here that this drug was already approved by the FDA, […]

Sanofi SA (ADR) (NYSE:SNY) Gets Clearance From The Competition Commission of India In Relation With Apollo Deal

Boston, MA 08/28/2014 (wallstreetpr) – According to reports, Sanofi SA (ADR) (NYSE:SNY) has got the green light from the Competition Commission of India in regard with its proposed purchase deal of an arm of Apollo. The representatives of CCI said that they did not found any sign of unfair business practice in this deal. What’s […]

Eli Lilly and Co (NYSE:LLY) Gets FDA Tentative Approval for Diabetes Drug

Boston, MA 08/19/2014 (wallstreetpr) – Eli Lilly and Co (NYSE:LLY) received positive news on its insulin injection that can be used to control sugar levels in diabetic patients after the FDA granted it tentative approval. The drug named, Basaglar, can be used to provide long lasting blood sugar control when patients are taking their meals […]

Sanofi SA (ADR) (NYSE:SNY), MannKind (NASDAQ:MNKD) In Afrezza Licensing Deal

Boston, MA 08/11/2014 (wallstreetpr) – French drug company Sanofi SA (ADR) (NYSE:SNY) and MannKind Corporation (NASDAQ:MNKD) have entered a global collaboration that involves developing and marketing of the inhaled insulin therapy, Afrezza, targeting adults with types 1 and 2 of diabetes. Afrezza is billed as rapid-acting inhaled insulin, a new solution for diabetes patients that […]

Sanofi SA (ADR) (NYSE:SNY) And Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Reported Success In Phase II Study With Rheumatoid Arthritis Drug

Boston, MA 06/12/2014 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced successful results from a Phase III study of experimental drug sarilumab in treating rheumatoid arthritis (RA) in patients who had previously shown no response to  methotrexate (MTX) treatment. The pharmaceutical companies presented their new data which demonstrated that sarilumab is capable […]

Sanofi SA (ADR) (NYSE:SNY) Loses Patent Protection

Boston, MA 10/22/2013 (wallstreetpr) – Sanofi SA (ADR) (NYSE:SNY) has been hit hard due to loss of patent protection in nine drugs in the last three years. The company is expecting a better fourth quarter. Increased competition from generic drugs is forcing such companies to invest heavily in R&D to develop new molecules. This is a […]